Keep one step ahead of the investing crowd

How to go the extra mile in doing real company research

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Is there any point trying to do in-depth research on companies whose shares you're considering?

You may think the obvious answer here is a resounding "yes", but this is an issue that splits the private investing community.

On the one hand, you have the "numbers only" approach beloved by value investors who refuse to let themselves get drawn in by a company with a good story to tell, or any other information which they see as extraneous to the value case.

On the other hand, there are many successful private investors who make a point of being more thorough and active in their research than pretty much anyone else.

A great example

One such example is a private investor named "David". David is well known for the thoroughness of his research. He often finds innovative ways of turning over the stones on a company, sometimes posing as a customer, or encouraging others to do the same.

His meticulous approach pays off. Since October 2011, his top six investments have enjoyed a mean average increase over 25%. Over the same period, the FTSE has added 1.3%. Not one of his six has lost ground. His actual performance has been a lot better than 25% as his largest holding has put on over 70%.

If I may place the larger Nautical Petroleum (LSE: NPE) and FW Thorpe (LSE: TFW) to one side for a moment, the average market capitalisation of the rest is just £34m. The relatively small size of the companies in this portfolio is the key here, for me. With large-cap companies, you're unlikely to be able to gain a real edge on the market as they're analysed to the nth degree. So, in these cases, the numbers-only approach helps iron out Mr Market's mood swings and can be an excellent way of gaining an edge.

And the same basic information is out there with small-cap companies. But once you've had a look at the last five years' worth of accounts, the company's products, R&D, patents, directors' CVs, market share, assets and so on, and formed a basic view, there are ways of going a lot further.

But how do you go the extra mile in really getting under the skin of a company and judging for yourself what its prospects are?

Here are a few suggestions:

Go to the AGM

One straightforward way of digging deeper is to attend the company's AGM and ask a few questions. Don't be too diffident in asking questions that may make you look more foolish than Foolish. After all, if you don't understand a company's performance and prospects, perhaps you shouldn't be investing?

Get on the phone

Another way is to ring up and ask any questions you have. From personal experience, I know you will need to be persistent here, but if you are, you'll usually end up talking to the CEO or the FD.

Be a customer

Being a customer is an excellent way of assessing a company's prospects if you can do it. If not, you may be able to ask real customers what they think.

Look for the clues around you

Investing legend Peter Lynch says that the clues are all around us. Staff, customers, suppliers, lawyers, accountants, advertising agencies, contractors and others may all have clues that a company is going well before the market does. Talking to these people is an excellent tactic if you can find them. This will help give you a good feel for trading and prospects.

Go there

If possible, visit the company's sites. If you're interested in a property's potential valuation, this is particularly useful.

Don't be a fool in love

Remember during this process never to "fall in love" with a share. This is the inherent risk when going into such research detail with a company.

The ASX is already on the move in 2012, and Goldman Sachs experts recently said they reckon S&P/ASX 200 could top 5,000 next year. Read This Before The Coming Market Rally is a must-read for investors who don't want to miss out on the party. Click here now to request your free copy, before it's too late.

Take Stock is The Motley Fool Australia's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Click here now to request your free subscription, whilst it's still available. This article contains general investment advice only (under AFSL 400691).

A version of this article, written by David Holding, originally appeared on

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »